Back to Search
Start Over
The side effects of side effects: the recent Institute of Medicine report pointed its institutional finger at the FDA over a variety of shortcomings surrounding drug safety post-marketing surveillance. Warren Ross reports on the potential ramifications for the pharmaceutical industry
- Source :
- Medical Marketing & Media. February 2007, Vol. 42 Issue 2, p46, 5 p.
- Publication Year :
- 2007
-
Abstract
- The pharmaceutical industry thrives on side effects. At first glance, that might seem like a flat contradiction of the facts. Think Vioxx--was that withdrawal good for Merck? Of course not. [...]
- Subjects :
- National Academy of Medicine -- Reports -- Safety and security measures
Complications and side effects
Reports
Safety and security measures
Anti-inflammatory agents -- Complications and side effects -- Reports -- Safety and security measures
Pharmaceutical industry -- Reports -- Safety and security measures
Anti-inflammatory drugs -- Complications and side effects -- Reports -- Safety and security measures
Subjects
Details
- Language :
- English
- ISSN :
- 00257354
- Volume :
- 42
- Issue :
- 2
- Database :
- Gale General OneFile
- Journal :
- Medical Marketing & Media
- Publication Type :
- Periodical
- Accession number :
- edsgcl.159786031